Advertisement
Advertisement
LMAT
LeMaitre Vascular, Inc.
110.77
USDSponsored
+2.70
+2.50%
Mar 16, 15:59 UTC -4
Closed
After-Market
110.69
-0.07
-0.06%
LMAT Earnings Reports
Positive Surprise Ratio
LMAT beat 27 of 41 last estimates.
66%
Next Report
Date of Next Report
Apr 29, 2026
Estimate for Q1 26 (Revenue/ EPS)
$67.74M
/$0.67
Implied change from Q4 25 (Revenue/ EPS)
+5.10%
/-1.47%
Implied change from Q1 25 (Revenue/ EPS)
+13.14%
/+39.58%
LeMaitre Vascular, Inc. earnings per share and revenue
On Feb 25, 2026, LMAT reported earnings of 0.68 USD per share (EPS) for Q4 25, beating the estimate of 0.67 USD, resulting in a 0.41% surprise. Revenue reached 64.45 million, compared to an expected 64.08 million, with a 0.58% difference. The market reacted with a +24.41% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 11 analysts forecast an EPS of 0.67 USD, with revenue projected to reach 67.74 million USD, implying an decrease of -1.47% EPS, and increase of 5.10% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
BillionToOne, Inc. Class A Common Stock
Report Date
Mar 04, 2026 For Q4 25
Estimate
$0.08
Actual
$0.11
Surprise
+27.02%
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Brainsway Ltd. - ADR
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.13
Actual
$0.14
Surprise
+6.63%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
Apyx Medical Corporation Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.63%
MacroGenics, Inc.
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.29
Actual
-$0.23
Surprise
+22.40%
Biote Corp. Class A Common Stock
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.05
Actual
$0.06
Surprise
+17.65%
Exagen Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.20
Surprise
-4.22%
Immucell Corp
Report Date
Mar 04, 2026 For Q4 25
Estimate
-Actual
-$0.31
Surprise
-
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
FAQ
What were LeMaitre Vascular, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, LeMaitre Vascular, Inc. reported EPS of $0.68, missing estimates by 0.41%, and revenue of $64.45M, 0.58% above expectations.
How did the market react to LeMaitre Vascular, Inc.'s Q4 2025 earnings?
The stock price moved up 24.41%, changed from $91.38 before the earnings release to $113.69 the day after.
When is LeMaitre Vascular, Inc. expected to report next?
The next earning report is scheduled for Apr 29, 2026.
What are the forecasts for LeMaitre Vascular, Inc.'s next earnings report?
Based on 11
analysts, LeMaitre Vascular, Inc. is expected to report EPS of $0.67 and revenue of $67.74M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement